slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 38,551-38,580
Pages 1,935
Rows per page 30
Slide function
38,551-38,580 of 58,039
11
Includes non-GAAP disclaimer at the bottom.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 1 hit
19
The chart uses a combination of a line graph for total applications and a bar chart for issued patents.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 1 hit
22
The chart uses a stacked bar format to visualize the composition of the install base over time.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 1 hit
28
The slide tracks the shift in revenue mix towards higher-margin channels.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 1 hit
29
Includes non-GAAP financial measures and constant currency growth rates.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 1 hit
31
Financial data in thousands, unaudited. Includes detailed footnotes explaining legal/transaction costs and restructuring/abandonment costs.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 1 hit
32
Includes footnotes explaining legal/transaction costs and the 2023 restructuring plan.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 1 hit
33
Note: $ in thousands, unaudited.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 1 hit
07
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Need1 hit
08
The slide shows two line charts tracking market share growth in different care settings.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Need1 hit
09
The slide highlights consistent growth in both metrics, with Q/Q growth percentages annotated above each bar.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Need1 hit
13
The slide illustrates how findings from one study (PIFR-1) informed the design of a subsequent study (PIFR-2) by narrowing the patient population to GOLD 3/4, resulting in statistically significant improvement.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
19
Includes GAAP and non-GAAP financial measures.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Action1 hit
20
The slide provides a standard financial reconciliation table.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Action1 hit
21
The slide includes specific footnotes regarding non-GAAP adjustments and share buyback activity.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Action1 hit
22
The chart shows a significant reduction in operating expenses from 2020 to 2023.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Action1 hit
24
The table displays projected royalties, net sales, and milestone payments from 2023 to 2026.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Action1 hit
30
Includes definitions for COPD, nOH, and PTE in the footer.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
32
The slide uses a split-panel layout to compare two distinct deal structures.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
08
The slide uses grouped bar charts to compare UBS and Credit Suisse performance metrics.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
09
The slide details the composition of the Non-core and Legacy (NCL) perimeter, highlighting the wind-down of Credit Suisse assets.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
14
The chart illustrates the impact of the Credit Suisse acquisition on 2Q23 results.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
16
The slide uses stacked bar charts to illustrate capital structure in absolute terms (bn) and relative terms (%), comparing current status to regulatory requirements.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
17
The chart shows the reduction of drawn SNB facilities from 120bn to 0 between March and August 2023.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
18
The chart uses a waterfall-like structure to bridge divisional performance to total group performance, highlighting the impact of integration-related expenses.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
19
The chart uses a standard waterfall bridge to show the transition from reported to adjusted figures.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
20
The slide uses a combination of a data table for revenues/expenses and a waterfall chart for pre-tax income, with a callout box explaining the Corporate Center losses.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
21
The slide uses a waterfall bridge to explain the transition from current performance to future targets.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
23
The slide compares current CET1 and leverage ratios against regulatory requirements (CET1 and TLAC) and provides qualitative updates on regulatory impacts.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
25
The slide uses a waterfall bridge framework to explain the variance between two reporting periods.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Action1 hit